Anika Therapeutics, Inc. ANIK
13.40 USD -0.41 (-2.97%)
At closeNov 13, 2026, 4:00 PM EST
13.40 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
13.26 Day range 13.97
9.01 52-week range 22.88
- YTD
- +39.44%
- 1 year
- +32.67%
News
seekingalpha.com Anika Therapeutics, Inc. (ANIK) Q3 2026 Earnings Call Transcript Anika Therapeutics, Inc. (ANIK) Q3 2026 Earnings Call Transcript
marketbeat.com What Anika Therapeutics (ANIK) Said on Its Q3 Earnings Call Anika Therapeutics NASDAQ: ANIK reported a 10% increase in third-quarter revenue and raised the lower end of its 2026 revenue and adjusted EBITDA margin forecasts, even as it lowered its commercial…
zacks.com Anika Therapeutics (ANIK) Beats Q3 Earnings and Revenue Estimates Anika Therapeutics (ANIK) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.04 per share a year ago.
benzinga.com Anika Therapeutics Q3 2026 Earnings Call Transcript Anika Therapeutics (NASDAQ:ANIK) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought…
benzinga.com Anika Therapeutics Raises FY2026 Sales Guidance from $118.460M-$124.101M to $119.588M-$124.101M vs $121.639M Est Anika Therapeutics (NASDAQ:ANIK) raises FY2026 sales outlook from $118.460 million-$124.101 million to $119.588 million-$124.101 million vs $121.639 million estimate.
benzinga.com Anika Therapeutics Q3 Adj. EPS $0.29 Beats $0.06 Estimate, Sales $30.594M Beat $29.436M Estimate Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.06 by 383.33 percent. This is a 625 percent increase over earnings of…
globenewswire.com Anika Reports Third Quarter 2026 Financial Results Revenue Increased 10% Year Over Year, Led by 17% Commercial Channel Growth Including More Than 30% Growth in IntegrityTM Revenue Secured New 10-Year Hyvisc® Partnership with Enhanced Economics;…
globenewswire.com Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026 BEDFORD, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue…
zacks.com Is Anika Therapeutics (ANIK) Outperforming Other Medical Stocks This Year? Here is how Anika Therapeutics (ANIK) and Concentra Group (CON) have performed compared to their sector so far this year.- benzinga.com B. Riley Securities Assumes Anika Therapeutics at Buy, Raises Price Target to $23 B. Riley Securities analyst Madison El-Saadi assumes Anika Therapeutics (NASDAQ:ANIK) with a Buy rating and raises Price Target to $23.
defenseworld.net Xencor (NASDAQ:XNCR) versus Anika Therapeutics (NASDAQ:ANIK) Head-To-Head Contrast Anika Therapeutics (NASDAQ: ANIK - Get Free Report) and Xencor (NASDAQ: XNCR - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two…
defenseworld.net Corient Private Wealth LP Takes Position in Anika Therapeutics Inc. $ANIK Corient Private Wealth LP bought a new stake in shares of Anika Therapeutics Inc. (NASDAQ: ANIK) during the undefined quarter, according to its most recent filing with the SEC. The firm bought 34,059…
defenseworld.net Hsbc Holdings PLC Invests $727,000 in Anika Therapeutics Inc. $ANIK Hsbc Holdings PLC purchased a new position in shares of Anika Therapeutics Inc. (NASDAQ: ANIK) during the second quarter, according to its most recent 13F filing with the Securities and Exchange…
zacks.com Best Momentum Stocks to Buy for August 26th BTSG, ANIK and OPHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 26th, 2026.
zacks.com Anika (ANIK) Is a Great Choice for 'Trend' Investors, Here's Why Anika (ANIK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our…
zacks.com Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why? ANIK's strong sales momentum and raised 2026 guidance bolster investor confidence, while Cingal and Hyalofast advance its pipeline.
zacks.com 5 Stocks With Recent Price Strength to Enhance Your Portfolio Returns Five stocks, including EDRY, OPHC, FET, ANIK and NESR, show strong recent price gains and earnings growth as markets rally.
zacks.com Anika Therapeutics (ANIK) Is Up 11.10% in One Week: What You Should Know Does Anika Therapeutics (ANIK) have what it takes to be a top stock pick for momentum investors? Let's find out.
zacks.com 5 Stocks With Recent Price Strength to Tap August Rally Five stocks, including OPHC, EDRY, ENVA, ANIK and GEO, show strong recent price gains and earnings growth as markets rally.
zacks.com Anika (ANIK) is on the Move, Here's Why the Trend Could be Sustainable Anika (ANIK) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our…
benzinga.com B. Riley Securities Maintains Buy on Anika Therapeutics, Raises Price Target to $21 B. Riley Securities analyst Anderson Schock maintains Anika Therapeutics (NASDAQ:ANIK) with a Buy and raises the price target from $18 to $21.
seekingalpha.com Anika Therapeutics, Inc. (ANIK) Q2 2026 Earnings Call Transcript Anika Therapeutics, Inc. (ANIK) Q2 2026 Earnings Call Transcript
marketbeat.com Anika Therapeutics Q2 Earnings Call Highlights Anika Therapeutics NASDAQ: ANIK reported higher second-quarter revenue, expanded gross margin and its strongest adjusted EBITDA performance since 2020, as international commercial growth and…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session Gainers Autonomix Medical (NASDAQ:AMIX) shares moved upwards by 62.5% to $4.47 during Wednesday's pre-market session. The company's market cap stands at $1.4 million. OneMedNet (NASDAQ:ONMD) shares…
benzinga.com Anika Therapeutics Raises FY2026 Sales Guidance from $114.000M-$122.500M to $118.460M-$124.101M vs $118.612M Est Anika Therapeutics (NASDAQ:ANIK) raises FY2026 sales outlook from $114.000 million-$122.500 million to $118.460 million-$124.101 million vs $118.612 million estimate.
globenewswire.com Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026 BEDFORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue…
globenewswire.com Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BEDFORD, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
benzinga.com Earnings Scheduled For April 29, 2026 
benzinga.com Anika Therapeutics Affirms FY2026 Sales Guidance of $114.000M-$122.500M vs $117.220M Est Anika Therapeutics (NASDAQ:ANIK) affirms FY2026 sales outlook from $114.000 million-$122.500 million to $114.000 million-$122.500 million vs $117.220 million estimate.- benzinga.com Anika Therapeutics Q1 Adj. EPS $0.27 Beats $(0.16) Estimate, Sales $29.612M Beat $28.142M Estimate Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $(0.16) by 268.75 percent. This is a 550 percent increase over losses of…
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
- benzinga.com Earnings Scheduled For February 26, 2026
benzinga.com Earnings Scheduled For November 5, 2025 - benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com Earnings Scheduled For July 30, 2025
benzinga.com Earnings Scheduled For May 9, 2025 
benzinga.com Why Intel Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - benzinga.com Earnings Scheduled For March 12, 2025
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com Earnings Scheduled For March 13, 2024 Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
- benzinga.com Earnings Scheduled For November 2, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 164 companies achieved new lows for the year.- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For August 14, 2023
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 128 companies set new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 155 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's trading, 188 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For August 8, 2023 Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly earnings at $0.21 per share on revenue of $1.48 billion.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 149 companies reached new 52-week lows.
benzinga.com Earnings Scheduled For May 9, 2023 Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.